These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17711919)

  • 1. Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men.
    Wide L; Naessén T; Sundström-Poromaa I; Eriksson K
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4410-7. PubMed ID: 17711919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women.
    Wide L; Eriksson K; Sluss PM; Hall JE
    J Clin Endocrinol Metab; 2009 Mar; 94(3):958-64. PubMed ID: 19116233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 17beta-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women.
    Wide L; Naessén T; Eriksson K
    Ups J Med Sci; 2010 May; 115(2):97-106. PubMed ID: 20141368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase.
    Wide L; Bakos O
    J Clin Endocrinol Metab; 1993 Apr; 76(4):885-9. PubMed ID: 8473400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17 beta-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause.
    Wide L; Naessén T
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):783-9. PubMed ID: 8033370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
    Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-glycosylated forms of both FSH and LH play major roles in the natural ovarian stimulation.
    Wide L; Eriksson K
    Ups J Med Sci; 2018 Jun; 123(2):100-108. PubMed ID: 29894213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation.
    Wide L; Eriksson K
    Ups J Med Sci; 2013 Aug; 118(3):153-64. PubMed ID: 23527482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause.
    Landgren BM; Collins A; Csemiczky G; Burger HG; Baksheev L; Robertson DM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2763-9. PubMed ID: 15181055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome.
    Wide L; Naessén T; Sundström-Poromaa I; Eriksson K
    J Endocr Soc; 2021 Jul; 5(7):bvab080. PubMed ID: 34159285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
    Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
    Buckler HM; McLachlan RI; MacLachlan VB; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Apr; 66(4):798-803. PubMed ID: 3126215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis.
    Padmanabhan V; Lang LL; Sonstein J; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1988 Sep; 67(3):465-73. PubMed ID: 3137241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.
    Cho LW; Jayagopal V; Kilpatrick ES; Holding S; Atkin SL
    Ann Clin Biochem; 2006 May; 43(Pt 3):217-9. PubMed ID: 16704758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome.
    Haider S; Mannan N; Khan A; Qureshi MA
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):463-6. PubMed ID: 25052966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.